For those with diabetes, insulin is just like a part of the body that they need every time. However, patients are hampered by its price increase, so a startup decided to create its version of cheap insulin.
rBIO Doubles Insulin Output Over Legacy Manufacturing Methods, Putting Company on Track to Reduce Insulin Costs by 30% - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ rBIO, an early-stage synthetic biology company focused on reducing the cost of increasingly costly biologic therapies, announced refinement of.
Researchers at Washington University School of Medicine in St. Louis have received a grant to develop the next generation of personal protective equipment (PPE) for combat troops.